Oesophageal cancer survival in Europe: a EUROCARE-4 study.

Oesophageal cancer survival is poor with variation across Europe. No pan-European studies of survival differences by oesophageal cancer subtype exist. This study investigates rates and trends in oesophageal cancer survival across Europe. Data for primary malignant oesophageal cancer diagnosed in 1995-1999 and followed up to the end of 2003 was obtained from 66 cancer registries in 24 European countries. Relative survival was calculated using the Hakulinen approach. Staging data were available from 19 registries. Survival by region, gender, age, morphology and stage was investigated. Cohort analysis and the period approach were applied to investigate survival trends from 1988 to 2002 for 31 registries in 17 countries. In total 51,499 cases of oesophageal cancer diagnosed 1995-1999 were analysed. Overall, European 1- and 5-year survival rates were 33.4% (95% CI 32.9-33.9%) and 9.8% (95% CI 9.4-10.1%), respectively. Males, older patients and patients with late stage disease had poorer 1- and 5-year relative survival. Patients with squamous cell carcinoma had poorer 1-year relative survival. Regional variation in survival was observed with Central Europe above and Eastern Europe below the European pool. Survival for distant stage disease was similar across Europe while survival rates for localised disease were below the European pool in Eastern and Southern Europe. Improvement in European 1-year relative survival was reported (p=0.016). Oesophageal cancer survival was poor across Europe. Persistent regional variations in 1-year survival point to a need for a high resolution study of diagnostic and treatment practices of oesophageal cancer.

[1]  A. Olshan,et al.  Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  J. Lagergren,et al.  Survival after surgery for oesophageal cancer: a population-based study. , 2005, The Lancet. Oncology.

[3]  D. Forman,et al.  Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. , 1998, European journal of cancer.

[4]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[5]  Mike Quinn,et al.  Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.

[6]  Jacques Ferlay,et al.  Trends in oesophageal cancer incidence and mortality in Europe , 2007, International journal of cancer.

[7]  D. Cunningham,et al.  Survival from cancer of the oesophagus in England and Wales up to 2001 , 2008, British Journal of Cancer.

[8]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[9]  A. Majeed,et al.  Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971–1998/1999 , 2003, Alimentary pharmacology & therapeutics.

[10]  A. Thrift,et al.  The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival , 2012, International journal of cancer.

[11]  V. Lemmens,et al.  Impact of concentration of oesophageal and gastric cardia cancer surgery on long‐term population‐based survival , 2011, The British journal of surgery.

[12]  E. Steyerberg,et al.  Outcome of esophagectomy for cancer in elderly patients. , 2010, The Annals of thoracic surgery.

[13]  G. Gatta,et al.  The advantage of women in cancer survival: an analysis of EUROCARE-4 data. , 2009, European journal of cancer.

[14]  J. Lagergren,et al.  Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. , 2008, European journal of cancer.

[15]  R. Goldbohm,et al.  Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study , 2009, Gut.

[16]  M. Coleman,et al.  The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. , 2009, European journal of cancer.

[17]  M. Feith,et al.  Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World , 2001, Annals of surgery.

[18]  L J Schouten,et al.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.

[19]  C. Divino,et al.  Racial Disparities in Esophageal Cancer Treatment and Outcomes , 2008, Annals of Surgical Oncology.

[20]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[21]  L. Stassen,et al.  High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Clinical Data , 2007, Annals of Surgical Oncology.

[22]  Lucia M. A. Crane,et al.  Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. , 2007, European journal of cancer.

[23]  M. Coleman,et al.  Survival from cancer of the oesophagus in England and Wales up to 2001 , 2008, British Journal of Cancer.

[24]  E. Kuipers,et al.  Increasing incidence of Barrett’s oesophagus in the general population , 2005, Gut.

[25]  M. Pera,et al.  Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[26]  P. Dickman,et al.  Improved survival in both histologic types of oesophageal cancer in Sweden , 2002, International journal of cancer.

[27]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[28]  F. Gilbert,et al.  Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients , 2004, Surgical Endoscopy And Other Interventional Techniques.

[29]  F. Berrino,et al.  Comparative cancer survival information in Europe. , 2009, European journal of cancer.

[30]  C. Robertson,et al.  Oesophageal cancer: A population‐based study of survival after treatment , 1992, The British journal of surgery.

[31]  K. Hess,et al.  Treatment Outcomes of Resected Esophageal Cancer , 2002, Annals of surgery.

[32]  R. Sankila,et al.  Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. , 2007, European journal of cancer.

[33]  C. Abnet,et al.  Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. , 2010, Journal of the National Cancer Institute.

[34]  J. Coebergh,et al.  Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study , 2004, European journal of gastroenterology & hepatology.

[35]  Á. Lanas,et al.  Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[36]  H Brenner,et al.  Deriving more up-to-date estimates of long-term patient survival. , 1997, Journal of clinical epidemiology.